SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis

Title
SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis
Authors
Keywords
-
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 110, Issue -, Pages 109024
Publisher
Elsevier BV
Online
2022-07-14
DOI
10.1016/j.intimp.2022.109024

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search